Indian-origin researcher says sleep apnea may give rise to liver disease in adultsAre you also suffering from sleep disorder like obstructive sleep apnea? If yes, then it's essential you realise that sleep apnea is not only affecting your moods, thoughts and body functions but may also give
Are you also suffering from sleep disorder like obstructive sleep apnea? If yes, then it's essential you realise that sleep apnea is not only affecting your moods, thoughts and body functions but may also give rise to liver disease.
Indian-origin researcher Shikha Sundaram has suggested in a new study that Obstructive Sleep Apnea (OSA) and low night-time oxygen are associated with the progression of non-alcoholic fatty liver disease (NAFLD) in adults.
According to the study, obstructive sleep apnea and low night-time oxygen may also be important triggers in the progression of paediatric NAFLD to non-alcoholic steatohepatitis (NASH) — a type of fatty liver disease, characterised by inflammation of the liver with concurrent fat accumulation in the liver.
Non-alcoholic fatty liver disease (NAFLD) is the accumulation of extra fat in liver cells in people who drink little or no alcohol.
Although isolated hepatic steatosis is considered a less aggressive form of NAFLD, patients with NASH can eventually progress to severe fibrosis and cirrhosis, with development of hepatocellular carcinoma in adults.
Sundaram, researcher at the University of Colorado School of Medicine, in the US said, “There is emerging evidence that obesity-related obstructive sleep apnea (OSA) and intermittent nocturnal hypoxia are associated with NAFLD progression. Paediatric NAFLD patients with OSA/hypoxia have more advanced liver disease and fibrosis, supporting a role for OSA/hypoxia in the development of NASH.”
Investigators studied 36 adolescents with NAFLD, along with 14 lean controls, to assess if oxidative stress induced by obstructive sleep apnea and low night-time oxygen promoted the progression of paediatric NAFLD. NAFLD patients had significantly raised aminotransferases (a marker of hepatocellular injury), inflammatory markers, and evidence of metabolic syndrome, compared to lean controls.
Patients underwent a standard multi-channel sleep study (polysomnogram). Investigators found that patients with the most severe NAFLD experienced more severe sleep-disordered breathing and significantly higher apnea/hypopnea index scores compared to those with less severe NAFLD.
Patients with OSA/hypoxia also had more severe fibrosis or scar tissue in their livers than those without OSA/hypoxia. They also found a clear correlation between severity of the indexes of oxidative stress both systemically and in the liver and the severity of the indexes used to evaluate OSA.
“These data show that sleep-disordered breathing is an important trigger of oxidative stress that promotes progression of paediatric NAFLD to NASH. We showed that obese adolescents with NAFLD who have OSA and low nighttime oxygen have significant scar tissue in their livers,” added Sundaram.
The findings are published in the Journal of Hepatology.
(With IANS inputs)